-transparent.png){kind=logo}
A five-year-old boy with acute myelogenous leukemia in relapse was treated by HLA-matched cord blood stem cell transplantation. The patient was preconditioned with 16 mg/kg of busulfan, 15 mg/kg of thiotepa and 90 mg/kg of cyclophosphamide and 2.45 x 10(7)/kg of cord blood mononuclear cells were infused to the patient on October 19th 1995 without the prophylaxis of graft-versus-host disease (GVHD). From the fifth day following the transplant, rG-CSF was administered at a dose of 300 micrograms/m2/day. Hematopoietic recovery was obtained as following; WBC over 1000/microliters was on +18 day, neutrophil over 500/microliters was on +20 day, reticulocyte over 20/1000 was on +28 day and platelet over 50 x 10(2) microliters was on +91 day. Engraftment was confirmed by DNA restriction fragment length polymorphism (VNTR) on +28 day. In spite of absence of prophylaxis of GVHD, the patient did not develop any signs of GVHD, and leukemia relapsed on +105 day. The patient died of leukemia relapse on +251 day. This is the first case of cord blood stem cell transplantation in Japan.
K Hattori, and
H Yabe, and
M Yabe, and
T Morimoto, and
K Iwasaki, and
Y Nakamura, and
S Inoguchi, and
K Tsuji, and
S Kato
June 2010,
Transplant infectious disease : an official journal of the Transplantation Society,
K Hattori, and
H Yabe, and
M Yabe, and
T Morimoto, and
K Iwasaki, and
Y Nakamura, and
S Inoguchi, and
K Tsuji, and
S Kato
November 1997,
Bone marrow transplantation,
K Hattori, and
H Yabe, and
M Yabe, and
T Morimoto, and
K Iwasaki, and
Y Nakamura, and
S Inoguchi, and
K Tsuji, and
S Kato
December 2008,
[Rinsho ketsueki] The Japanese journal of clinical hematology,
K Hattori, and
H Yabe, and
M Yabe, and
T Morimoto, and
K Iwasaki, and
Y Nakamura, and
S Inoguchi, and
K Tsuji, and
S Kato
September 2014,
World journal of stem cells,
K Hattori, and
H Yabe, and
M Yabe, and
T Morimoto, and
K Iwasaki, and
Y Nakamura, and
S Inoguchi, and
K Tsuji, and
S Kato
February 1998,
[Rinsho ketsueki] The Japanese journal of clinical hematology,
K Hattori, and
H Yabe, and
M Yabe, and
T Morimoto, and
K Iwasaki, and
Y Nakamura, and
S Inoguchi, and
K Tsuji, and
S Kato
May 1994,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
K Hattori, and
H Yabe, and
M Yabe, and
T Morimoto, and
K Iwasaki, and
Y Nakamura, and
S Inoguchi, and
K Tsuji, and
S Kato
September 1999,
Gan to kagaku ryoho. Cancer & chemotherapy,
K Hattori, and
H Yabe, and
M Yabe, and
T Morimoto, and
K Iwasaki, and
Y Nakamura, and
S Inoguchi, and
K Tsuji, and
S Kato
February 2009,
Transplant infectious disease : an official journal of the Transplantation Society,
K Hattori, and
H Yabe, and
M Yabe, and
T Morimoto, and
K Iwasaki, and
Y Nakamura, and
S Inoguchi, and
K Tsuji, and
S Kato
August 2008,
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
K Hattori, and
H Yabe, and
M Yabe, and
T Morimoto, and
K Iwasaki, and
Y Nakamura, and
S Inoguchi, and
K Tsuji, and
S Kato
February 2003,
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases,
